Monoclonal antibodies against interleukin 13 and interleukin 31RA in development for atopic dermatitis

Medicin og biovidenskab

• Interleukin-13 100%
• Interleukins 96%
• Atopic Dermatitis 91%
• Monoclonal Antibodies 64%
• Eczema 50%
• Antibodies, Monoclonal, Humanized 28%
• Pruritus 22%
• Sleep 17%
• Asthma 17%
• Central Nervous System 16%
• Clinical Trials 14%
• Cytokines 13%
• Safety 12%
• Antibodies 12%
• Therapeutics 10%